MGMiguel Guedes

Miguel Guedes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miguel Guedes has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: Neuroprotective and anti-inflammatory activities

    by Joana Silva, Celso Alves, Susete Pinteus, Patrícia Susano, Marco Simões, Miguel Guedes, Alice Martins, Stephanie Rehfeldt, Helena Gaspar, Márcia Goettert, et al.


  • Open Access

    Loliolide, a New Therapeutic Option for Neurological Diseases? In Vitro Neuroprotective and Anti-Inflammatory Activities of a Monoterpenoid Lactone Isolated from Codium tomentosum

    by Joana Silva, Celso Alves, Alice Martins, Patrícia Susano, Marco Simões, Miguel Guedes, Stephanie Rehfeldt, Susete Pinteus, Helena Gaspar, Américo Rodrigues, et al.

    Parkinsons Disease (PD) is the second most common neurodegenerative disease worldwide, and is characterized by a progressive degeneration of dopaminergic neurons. Without an effective treatment, it is crucial to find new therapeutic options to fight the neurodegenerative process, which may arise from marine resources. Accordingly, the goal of the present work was to evaluate the ability of the monoterpenoid lactone Loliolide, isolated from the green seaweed Codium tomentosum, to prevent neurological cell death mediated by the neurotoxin 6-hydroxydopamine (6-OHDA) on SH-SY5Y cells and their anti-inflammatory effects in RAW 264.7 macrophages. Loliolide was obtained from the diethyl ether extract, purified through column chromatography and identified by NMR spectroscopy. The neuroprotective effects were evaluated by the MTT method. Cells’ exposure to 6-OHDA in the presence of Loliolide led to an increase of cells’ viability in 40%, and this effect was mediated by mitochondrial protection, reduction of oxidative stress condition and apoptosis, and inhibition of the NF-kB pathway. Additionally, Loliolide also suppressed nitric oxide production and inhibited the production of TNF-α and IL-6 pro-inflammatory cytokines. The results suggest that Loliolide can inspire the development of new neuroprotective therapeutic agents and thus, more detailed studies should be considered to validate its pharmacological potential.


  • Open Access

    Evaluation of the antimicrobial activity of the intestinal microbiota of Sparus aurata (Linnaeus, 1758)

    by Joana Alves, Miguel Guedes, Adriana Januário, Teresa Baptista, Clélia Afonso

    The production of organisms in aquaculture systems has been increasing exponentially in the last years as to prevent overexploitation of marine resources, a consequence of a massive growth of the global population numbers and rise in consumption of fish protein. Although aquaculture industry allows a faster production of selected organisms, a major problem, faced constantly, is the exposure of individuals to chronical stress and pathogenic organisms, factors responsible for high economical failures in the sector. Most of these pathogens belong to the Vibrionaceae family, which are fought by the extensive use of chemicals and antibiotics, therefore creating more resistant strains while leading to increasing levels of pollution, trough organic matter discharges into the marine environment [1-4]. Considerable investments have been made to discover new compounds with compelling properties, with a major part of the research made, focusing on the use of marine probiotics. These are marine microorganisms, fungi or bacteria, that when consumed benefit the health of the host organism, namely being able of inhibiting the activity of some pathogenic agents [1,2]. Several studies have successfully shown the interesting properties of probiotics obtained from different species of fish. Sparus aurata (Linnaeus, 1758), most commonly known as gilthead seabream, can be found abundantly on the Atlantic shore and is intensively grown in aquaculture systems. The constant exposure of these individuals to a wide range of pathogens, promotes the development of defence mechanisms [1,2]. This study evaluates the antimicrobial activity of the intestinal microbiota of S. aurata against Vibrio alginolyticus, Vibrio harveyi and Vibrio anguillarum, using the Disk-Diffusion method. For this purpose, the intestinal content of gilthead seabream, obtained from the marine environment, was suspended in NaCl solution (1.5%). Bacterial suspensions (100 μL) were spread in Tryptic Soy Agar (TSA) culture medium supplemented with NaCl (1.5%) (VWR) and in selective culture medium Thiosulfate-Citrate-Bile Salts-Sucrose (TCBS agar, VWR). Plates were incubated at 37°C and 30°C, respectively. After an incubation period of 92 hours, 20 colonies with distinct morphology were selected. These were collected and pure colonies were isolated. Colonies were grown in the liquid media previously indicated and placed in a shaking incubator (IKA, Germany). Cells were lysed through sonication, followed by centrifugation for 10 minutes, full speed. The resulting lysates were stored at -20°C. In order to test the pathogen exclusion competence, samples were then added to Mueller-Hinton plates containing one of the three pathogenic agents in study, along with a negative control and a positive control disk (chloramphenicol, 30μg/mL, Oxoid). After incubation for 24 hours the inhibition of pathogen growth wasn’t registered for none of the Vibrio strains. Even though the intestinal microbiota of Sparus aurata didn’t trigger an inhibitory effect on the growth of the pathogenic organisms, more research should be made on this subject, using a more extensive range of pathogenic organisms and samples sources.